Alberta Collaborative QI Strategies to Improve Outcomes of Moderate and Late Preterm Infan
The ABC-QI Trial aims to implement collaborative quality improvement (QI) strategies to standardize care for 32-36 week infants in Level 2 and 3 Neonatal intensive care units (NICUs) across the province of Alberta. The investigators want to know if using validated quality improvement methods and evidence-based care bun
| Condition(s) | Length of Stay |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The ABC-QI Trial aims to implement collaborative quality improvement (QI) strategies to standardize care for 32-36 week infants in Level 2 and 3 Neonatal intensive care units (NICUs) across the province of Alberta. The investigators want to know if using validated quality improvement methods and evidence-based care bundles will decrease the duration of hospital stay and get babies home as quickly as possible. |
| Who can participate | Inclusion Criteria: Preterm Infants: Infants born at 32 to 36 weeks' gestation and admitted to the participating NICUs or postpartum units. Quality Improvement Implementation Survey version 2 (QIIS-II) and semi-structured interview participants: Management staff, nurses, nurse practitioners, physicians, and allied health staff employed in participating NICUs. Exclusion Criteria: * Preterm Infants: * Major congenital anomalies or chromosomal abnormalities. * Primary admission to a surgical NICU: Alberta Children's Hospital or Stollery Children's Hospital. * Infants born in or transferred to a NICU outside Alberta. * Patients who have imposed confidentiality restrictions on accessing their health records. |
| Ages | 32 Weeks to 36 Weeks |
| Sex | All |
| Lead sponsor | University of Calgary |
| Locations | Calgary, Alberta, Canada; Calgary, Alberta, Canada; Calgary, Alberta, Canada; Calgary, Alberta, Canada; Calgary, Alberta, Canada; Edmonton, Alberta, Canada (+6 more sites) |
| Start date | 2023-05-01 |
| NCT ID | NCT05231200 |
| Official listing | https://clinicaltrials.gov/study/NCT05231200 |